ABBV-295
A Study of ABBV-295 Subcutaneous Injections to Assess Pharmacokinetics and Adverse Events in Healthy Adult Women Participants With Overweight or Obesity Taking Oral Contraceptives
AbbVie · Phase 1 · Completed · Enrollment 20
No selected arm has a reported week for this endpoint.
A solid line connects the weeks the source reports.